SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 02, 2005. The document serves as a notification of transactions involving Persons Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a). It is not a financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly limited to executive share option exercises.
Material Changes
No material changes to the company's financial position or operations are reported. The filing details the following specific transactions executed on December 01, 2005:
- Mr. R Bondy: Exercised options over 1,031 Ordinary shares granted on December 01, 2002, under the GlaxoSmithKline Savings Related Share Option Scheme at a price of GBP 9.16 per share.
- Mr. M Dunoyer: Exercised options over 1,031 Ordinary shares granted on December 01, 2002, under the GlaxoSmithKline Savings Related Share Option Scheme at a price of GBP 9.16 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the total number of shares issued to Mr. Bondy and Mr. Dunoyer (1,031 shares each) against the company's cap table.
- Confirm the exercise price of GBP 9.16 per share aligns with the grant date of December 01, 2002.
- Note that this filing does not contain financial performance data for the period.